allelic variants cystic fibrosis cf transmembrane conductance regulator cftr independently contribute pulmonary outcome cf patients resolved used longitudinal analyses data cf patients NUMBER years old determine influence pulmonary function percent predicted forced expiratory volume fev1 cftr gene genotype gender mucoid pseudomonas aeruginosa mpa infection status presence total opsonic antibody mpa separately opsonic antibody activity specific mucoid exopolysaccharide mep surface antigen different factors independently associated lack mpa infection high level opsonic activity msoa implicating immunologically based mechanism resistance infection lack type opsonic antibody mpa indicative significant exposure infection phenotype subset cf patients carried uncommon cftr gene allele suggestive genetic basis resistance infection group older cf patients cf patients cftr gene alleles identified screening NUMBER common variants NUMBER alleles analysis showed mpa infection best correlated lower percent predicted fev1 genotype versus deltaf508 cftr gene allele low level msoa associated increased risk infection analysis longitudinal spirometric measurements considered multiple risk factors derive regression equations used determine clinical parameters greatest effect annual rate decline percent predicted fev1 analysis showed cftr gene genotype modestly modified constant y intercept derived equations gender mpa infection status largest effects annual rates decline percent predicted fev1 results indicate cftr genotype usually primary determinant pulmonary function cf patients gender mpa infection status infection status potentially influenced immunologic high level msoa genetic factors carriage cftr gene allele leads diagnosis cf confers resistance infection comparable cftr gene cross sectional mixed model mep specific cross sectional mixed model wild type